MedTrace Logo

Pharmacokinetic Study: Effect of 25(OH)D and Vitamin D3 on Serum 25(OH)D

NCT00718276 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2011-12-23

No results posted yet for this study

Summary

We compare the effect of HyD (25-hydroxyvitamin D) and vitamin D3 in their effect on 25-hydroxyvitamin D plasma levels over a course of 4 month. This is a pharmacokinetic study including 35 postmenopausal women.

* Trial with medicinal product

Conditions

  • Healthy

Interventions

DRUG

25(OH)D

daily (20ug), weekly (140 ug), Bolus (140 ug)

DIETARY_SUPPLEMENT

vitamin D3

daily (800 IU), weekly (5600 IU), Bolus (5600 Iu)

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Heike Bischoff Ferrari, MD, MPH · University Hospital Zurich, Centre on Aging and Mobility

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-08-31
Completion
2008-09-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00718276 on ClinicalTrials.gov